LQDA
Liquidia Corp
Pharmaceutical PreparationsNasdaqNon-accelerated filer<br>Smaller reporting company
Total Trades
198
Buys
14
Sells
114
Largest Trade
N/A
Insiders
12
Institutional Funds
167
Inst. Value
$1M+
Activist Filings
17
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Schundler Russell | General Counsel | EXERCISE | N/A | 2K | — | Mar 3, 2026 |
| Schundler Russell | General Counsel | SELL | $15K–$50K | 1K | $30.58 | Mar 3, 2026 |
| Moomaw Scott | Chief Commercial O… | SELL | $15K–$50K | 827 | $30.58 | Mar 3, 2026 |
| Moomaw Scott | Chief Commercial O… | EXERCISE | N/A | 2K | — | Mar 3, 2026 |
| Krepp Sarah | Chief Human Resour… | SELL | $1K–$15K | 276 | $30.58 | Mar 3, 2026 |
| Kaseta Michael | CFO and COO | SELL | $15K–$50K | 1K | $30.58 | Mar 3, 2026 |
| Kaseta Michael | CFO and COO | EXERCISE | N/A | 2K | — | Mar 3, 2026 |
| Boyle Dana | Chief Accounting O… | SELL | $1K–$15K | 445 | $30.58 | Mar 3, 2026 |
| Adair Jason | Chief Business Off… | EXERCISE | N/A | 2K | — | Mar 3, 2026 |
| Adair Jason | Chief Business Off… | SELL | $15K–$50K | 689 | $30.58 | Mar 3, 2026 |
| Boyle Dana | Chief Accounting O… | SELL | $50K–$100K | 2K | $41.65 | Jan 28, 2026 |
| Adair Jason | Chief Business Off… | SELL | $15K–$50K | 688 | $41.65 | Jan 28, 2026 |
| Krepp Sarah | Chief Human Resour… | SELL | $100K–$500K | 13K | $37.43 | Jan 13, 2026 |
| Krepp Sarah | Chief Human Resour… | EXERCISE | N/A | 13K | — | Jan 13, 2026 |
| Moomaw Scott | Chief Commercial O… | SELL | $500K+ | 21K | $37.43 | Jan 13, 2026 |
| Moomaw Scott | Chief Commercial O… | EXERCISE | N/A | 21K | — | Jan 13, 2026 |
| Kaseta Michael | CFO and COO | EXERCISE | N/A | 34K | — | Jan 13, 2026 |
| Kaseta Michael | CFO and COO | SELL | $1M+ | 37K | $37.43 | Jan 13, 2026 |
| Adair Jason | Chief Business Off… | SELL | $500K+ | 14K | $37.43 | Jan 13, 2026 |
| Adair Jason | Chief Business Off… | EXERCISE | N/A | 22K | — | Jan 13, 2026 |
| Schundler Russell | General Counsel | SELL | $1M+ | 27K | $37.43 | Jan 13, 2026 |
| Schundler Russell | General Counsel | EXERCISE | N/A | 29K | — | Jan 13, 2026 |
| JEFFS ROGER | CEO | EXERCISE | N/A | 71K | — | Jan 13, 2026 |
| JEFFS ROGER | CEO | SELL | $1M+ | 67K | $37.43 | Jan 13, 2026 |
| Boyle Dana | Chief Accounting O… | SELL | $100K–$500K | 11K | $37.43 | Jan 13, 2026 |
| Boyle Dana | Chief Accounting O… | EXERCISE | N/A | 13K | — | Jan 13, 2026 |
| Saggar Rajeev | Chief Medical Offi… | SELL | $500K+ | 21K | $37.43 | Jan 13, 2026 |
| Saggar Rajeev | Chief Medical Offi… | EXERCISE | N/A | 21K | — | Jan 13, 2026 |
| Schundler Russell | General Counsel | EXERCISE | N/A | 2K | — | Dec 2, 2025 |
| Schundler Russell | General Counsel | SELL | $15K–$50K | 1K | $32.19 | Dec 2, 2025 |
| Krepp Sarah | Chief Human Resour… | SELL | $1K–$15K | 221 | $32.19 | Dec 2, 2025 |
| Kaseta Michael | CFO and COO | SELL | $15K–$50K | 1K | $32.19 | Dec 2, 2025 |
| Kaseta Michael | CFO and COO | EXERCISE | N/A | 2K | — | Dec 2, 2025 |
| Boyle Dana | Chief Accounting O… | SELL | $1K–$15K | 303 | $32.19 | Dec 2, 2025 |
| Adair Jason | Chief Business Off… | EXERCISE | N/A | 2K | — | Dec 2, 2025 |
| Adair Jason | Chief Business Off… | SELL | $15K–$50K | 693 | $32.19 | Dec 2, 2025 |
| Moomaw Scott | Chief Commercial O… | EXERCISE | N/A | 2K | — | Dec 2, 2025 |
| Moomaw Scott | Chief Commercial O… | SELL | $15K–$50K | 831 | $32.19 | Dec 2, 2025 |
| Adair Jason | Chief Business Off… | EXERCISE | $100K–$500K | 36K | $5.89 | Nov 20, 2025 |
| Adair Jason | Chief Business Off… | SELL | $1M+ | 36K | $30.03 | Nov 20, 2025 |
| Boyle Dana | Chief Accounting O… | SELL | $500K+ | 29K | $25.09 | Nov 12, 2025 |
| Saggar Rajeev | Chief Medical Offi… | SELL | $1M+ | 71K | $27.00 | Nov 7, 2025 |
| Adair Jason | Chief Business Off… | SELL | $15K–$50K | 692 | $22.93 | Oct 29, 2025 |
| Boyle Dana | Chief Accounting O… | SELL | $15K–$50K | 1K | $22.93 | Oct 29, 2025 |
| SINGH RAMAN | Director | SELL | $1M+ | 46K | $25.81 | Sep 17, 2025 |
| SINGH RAMAN | Director | EXERCISE | $100K–$500K | 46K | $2.55 | Sep 17, 2025 |
| SINGH RAMAN | Director | SELL | $100K–$500K | 8K | $29.42 | Sep 5, 2025 |
| Moomaw Scott | Chief Commercial O… | EXERCISE | N/A | 2K | — | Sep 3, 2025 |
| Moomaw Scott | Chief Commercial O… | SELL | $1M+ | 71K | $28.63 | Sep 3, 2025 |
| Schundler Russell | General Counsel | SELL | $15K–$50K | 1K | $29.05 | Sep 3, 2025 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 167 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Caligan Partners LP | 8.1M | $1M+ | SH |
| FINDELL CAPITAL MANAGEMENT LLC | 2.9M | $1M+ | SH |
| STATE STREET CORP | 1.8M | $1M+ | SH |
| Caprock Group, LLC | 1.8M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.4M | $1M+ | SH |
| MPM BioImpact LLC | 1.4M | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 562K | $1M+ | SH |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 532K | $1M+ | SH |
| Point72 Asset Management, L.P. | 500K | $1M+ | SH (Put) |
| PRUDENTIAL FINANCIAL INC | 411K | $1M+ | SH |
| Pale Fire Capital SE | 379K | $1M+ | SH |
| APIS CAPITAL ADVISORS, LLC | 355K | $1M+ | SH |
| FIRST TRUST ADVISORS LP | 307K | $1M+ | SH |
| Patient Square Capital LP | 227K | $1M+ | SH |
| GOLDMAN SACHS GROUP INC | 226K | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 207K | $1M+ | SH |
| T3 Companies, LLC | 176K | $1M+ | SH |
| HRT FINANCIAL LP | 168K | $1M+ | SH |
| Whitefort Capital Management, LP | 158K | $1M+ | SH |
| Walleye Capital LLC | 155K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Farallon Capital Partners, L.P.
SC 13G/A · Feb 9, 2026
0.8%
691K shares
Farallon Capital Partners, L.P.
SC 13G/A · Nov 12, 2025
0.9%
747K shares
Farallon Capital Partners, L.P.
SC 13G · Jul 11, 2025
0.9%
786K shares
SC 13G/A · Feb 12, 2025
2.2%
1.9M shares
SC 13G/A · Nov 12, 2024
7.9%
6.7M shares
SC 13G · Nov 8, 2024
5.0%
4.2M shares
SC 13G · Oct 18, 2024
5.0%
4.2M shares
SC 13D/A · Sep 12, 2024
9.6%
8.1M shares
SC 13D/A · Sep 4, 2024
9.1%
7.0M shares
SC 13G/A · Feb 14, 2024
9.2%
6.3M shares
SC 13G · Jan 31, 2024
5.2%
3.5M shares
SC 13G · Jan 16, 2024
9.5%
7.2M shares
SC 13D/A · Dec 14, 2023
15.1%
10.4M shares
SC 13G · May 5, 2023
5.0%
3.2M shares
SC 13G/A · Feb 14, 2023
9.3%
6.0M shares
SC 13G/A · Feb 1, 2023
4.5%
2.9M shares
SC 13G/A · Feb 14, 2022
10.0%
5.2M shares